Search clinical trials for: superpotent topical corticosteroids

Total 3839 results

CHU de Reims

Completed

Efficacy and Safety of Ustekinumab in Bullous Pemphigoid (PB-USTE)

Bullous Pemphigoid

France
LEO Pharma

Not yet recruiting

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis (TRAPEDS 2)

Atopic Dermatitis

United States
Sanofi

Recruiting

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor (AQUA)

Dermatitis Atopic

Chile, United Kingdom, United States, Canada, Turkey, Israel, Korea, Republic of
Sanofi

Recruiting

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids (SHORE)

Dermatitis Atopic

Japan, Chile, Canada, Argentina, United States, Turkey, China
University Hospital, Bordeaux

Recruiting

Screening for Adrenal Insufficiency During Dermocorticoid Reduction in Bullous Pemphigoid (BP) (PB-DEPIST)

Pemphigoid, Bullous | Adrenal Insufficiency

France
October 6 University
Cairo University

Recruiting

Efficacy of Probiotic Capsules With Topical Clobetasol Propionate in OLP Treatment

Oral Lichen Planus

Egypt
Fundación Academia Española de Dermatología

Recruiting

Spanish Academy of Dermatology and Venereology Registry of Atopic Dermatitis Therapy (BIOBADATOP)

Dermatitis, Atopic

Spain
Jacob Pontoppidan Thyssen
The Novo Nordic Foundation

Recruiting

Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis

Atopic Dermatitis | Atopic Dermatitis Eczema | Atopic Dermatitis Flare

Denmark
Sanofi

Recruiting

Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials (RIVER-AD)

Dermatitis Atopic

Canada, United States, Australia, Bulgaria, Czechia, Germany, Hungary, Japan, Poland, Spain, Taiwan, United Kingdom
Al-Azhar University

Recruiting

Efficacy of Jessener Solution Versus Intralesional Steroid in Treatment of Alopecia Areata (AA)

Alopecia Areata

Egypt
Erasmus Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Recruiting

NMF-CsA-Dupi Trial

Dermatitis, Atopic

Netherlands
University Hospital, Toulouse

Recruiting

Efficacy and Safety of Dupilumab Chronic Hands Eczema Refractory to Highly Potent Topical Corticosteroids (DUPECZEMAIN)

Chronic Hand Eczema

France
Eli Lilly and Company
Incyte Corporation

Completed

A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisable (BREEZE-AD4)

Atopic Dermatitis

Belgium, Netherlands, Japan, Spain, Switzerland, United Kingdom, Germany, France, Austria, Russian Federation, Poland, Italy, Brazil, Finland
Almirall, S.A.

Completed

A Study of Lebrikizumab in Combination With Topical Corticosteroids in Participants Having Atopic Dermatitis (AD) That Are Not Adequately Controlled or Non-eligible for Cyclosporine

Eczema | Dermatitis, Atopic

Austria, Belgium, France, Germany, Netherlands, Poland, Spain, United Kingdom
AbbVie

Enrolling by invitation

A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis (AD Up)

Atopic Dermatitis

United States, Australia, Austria, Belgium, Canada, China, Czechia, France, Germany, Greece, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Netherlands, New Zealand, Norway, Puerto Rico, Slovakia, Spain, Sweden, United Kingdom
CHU de Reims

Completed

Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous Pemphigoid (EDP-PB)

Bullous Pemphigoid

France
Cairo University

Completed

Micronutrients in Management of Symptomatic Oral Lichen Planus

Oral Lichen Planus

Egypt
Cairo University

Active, not recruiting

Topical Sulfasalazine and Oral Lichen Planus

Oral Lichen Planus | Corticosteroids | Topical Sulfasalazine

Egypt
Eli Lilly and Company

Completed

A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis (ADhere-J)

Skin Diseases | Skin Diseases, Genetic | Dermatitis | Eczema | Dermatitis, Atopic

Japan
Hospital for Special Surgery, New York

Completed

Effect of Topical Corticosteroids on Dysphagia in Anterior Cervical Discectomy and Fusion

Dysphagia | Cervical Disc Herniation | Cervical Degenerative Disc Disease | Cervical Spondylotic Myelopathy | Osteoarthritis of Cervical Spine
LEO Pharma

Completed

Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis - ECZTRA 7 (ECZTRA 7)

Atopic Dermatitis

Belgium, France, Germany, Poland, United Kingdom, Czechia, Spain
Basilea Pharmaceutica

Completed

Alitretinoin in the Treatment of Chronic Hand Eczema

Eczema

France, Germany
AbbVie

Completed

A Study to Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis (Rising Up)

Atopic Dermatitis

Japan
Sanofi
Regeneron Pharmaceuticals

Completed

Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2)

Neurodermatitis

United States, Canada, Chile, France, Hungary, Italy, Korea, Republic of, Portugal, Spain, Taiwan, United Kingdom
Sanofi
Regeneron Pharmaceuticals

Completed

Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME)

Neurodermatitis

France, United States, Argentina, China, Japan, Korea, Republic of, Mexico, Russian Federation
LEO Pharma

Completed

Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic Dermatitis (ECZTRA 8)

Atopic Dermatitis

Japan
Sheba Medical Center

Completed

Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis

Ulcerative Colitis

Israel, China, France, Greece, Italy, Korea, Republic of, Serbia
MEDA Pharma GmbH & Co. KG

Completed

5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States, Germany
University Hospital, Montpellier

Completed

Topical Steroids Alone or Associated With Methotrexate in Bullous Pemphigoid (BP/MTX)

Bullous Pemphigoid

France
David Weinstein

Terminated

Study of the Efficacy of 532nm Laser and 1064 nm Laser in the Treatment of Cutaneous Lupus Erythematous Versus Topical Corticosteroids Alone

Cutaneous Lupus

United States
Jacob Thyssen
LEO Pharma

Completed

The Effects of Topical Corticosteroid Use on Insulin Sensitivity and Bone Turnover

Atopic Dermatitis | Atopic Eczema

Denmark
LEO Pharma

Completed

Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3

Atopic Dermatitis

United States, Germany, Belgium, Canada, Spain, United Kingdom, Poland, Netherlands
Galapagos NV

Terminated

A Study to Evaluate the Safety and Tolerability of MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Participants With Moderate to Severe Atopic Dermatitis (GECKO)

Atopic Dermatitis

United States
Regeneron Pharmaceuticals
Sanofi

Completed

Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)

Dermatitis, Atopic

United States, Germany, Poland, Canada, Czechia, United Kingdom
Eli Lilly and Company
Incyte Corporation

Completed

A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis (BREEZE-AD7)

Atopic Dermatitis

Spain, Australia, Korea, Republic of, Poland, Italy, Germany, Argentina, Austria, Japan, Taiwan
Hams Hamed Abdelrahman

Completed

Glutamine With Topical Corticosteroids for Lichen Planus Treatment

Lichen Penis Planus

Egypt
New England Retina Associates
Ocular Therapeutix

Unknown

Evaluation of DEXTENZA in the Management of Pain and Inflammation in Patients With Anterior Uveitis Compared to Standard of Care Topical Corticosteroids (DiverT)

Non-infectious Anterior Uveitis
LEO Pharma
Bayer

Completed

An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical Corticosteroids (Ointment TS-AD)

Dermatitis, Atopic

Japan
National University Health System, Singapore

Completed

Efficacy of Targeted Intervention for Topical Steroid Phobia.

Adherence, Medication | Phobia | Dermatologic Disease

Singapore
Hoffmann-La Roche

Completed

A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis

Atopic Dermatitis

United States, Canada
Cairo University

Completed

Effect of Adjunctive Systemic Vitamin E on Clinical Parameters and Salivary Total Antioxidant Capacity in Symptomatic Oral Lichen Planus Patients: Randomized-controlled Clinical Trial

Oral Lichen Planus

Egypt
Cairo University

Unknown

Clinical and Biochemical Assessment of the Effect of Topical Use of Coenzyme Q10 Versus Topical Corticosteroid in Management of Symptomatic Oral Lichen Planus: Randomized Controlled Clinical Trial

Oral Lichen Planus
Cairo University

Unknown

Diode Laser Versus Topical Corticosteroids in Management of Oral Ulcers in Behcet's Disease (BD)

Behcet Syndrome | Autoimmune
Cairo University

Unknown

The Effect of Topical Curcumin Versus Topical Corticosteroid on Management of Oral Lichen Planus Patients

Oral Lichen Planus
Ben-Gurion University of the Negev
Soroka University Medical Center

Unknown

Potency of Topical Corticosteroids in Combination Preparations

Skin Toxicity
Dr Adolf Lukanovič
Juna d.o.o.

Unknown

Nd:Yttrium Aluminum Garnet Laser Treatment for Lichen Sclerosus

Lichen Sclerosus | Lichen Sclerosus Et Atrophicus
Radboud University Medical Center

Unknown

Efficacy of Topical Coal Tar in Children With Atopic Dermatitis

Atopic Dermatitis

Netherlands
Cairo University

Unknown

Efficacy of Green Tea Buccal Tablets in Oral Lichen Planus

Oral Lichen Planus

Egypt
Hospital Italiano de Buenos Aires

Unknown

Cochlear Electrical Impedance and the Effect of Topical Dexamethasone on Cochlear Implant Surgery

Sensorineural Hearing Loss | Cochlear Implant

Argentina
Regeneron Pharmaceuticals
Sanofi

Completed

Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD)

Atopic Dermatitis

Poland, Germany, Hungary

3

Subscribe